To the SIO Community, As we enter the busy holiday season, public health and safety is top of mind for all of us. The recent news surrounding COVID-19 is a reminder that while we continue to navigate new challenges, the medical advances we have seen in the last year are making it possible for us to
The Society of Interventional Oncology (SIO) announces the launch of the society’s first clinical trial, “Ablation with Confirmation of Colorectal Liver Metastases (ACCLAIM) Prospective Trial for Microwave Ablation as a Local Cure.”
To the SIO Community, On behalf of the SIO Board of Directors and staff, I hope this note finds you in good health and good spirits. I write to you all today to share that SIO is committed to holding a safe, enjoyable Annual Scientific Meeting in San Francisco, 3-7 February 2022.
Dear Colleagues, I would like to open this message with a warm thank you to all the attendees, supporters, organizers, faculty, staff and other volunteers who helped make our SIO2021 Virtual Annual Scientific Meeting a success.
The SIO NCCN Task Force submitted recommendations to the NCCN for the latest revision of the Neuroendocrine Tumor treatment guidelines. Rony Avritscher from MD Anderson Cancer Center, Nick Fidelman from UCSF, and Etay Ziv from Memorial Sloan Kettering Cancer Center authored the SIO submission.
COVID19 poses a real threat to the well-being of our patients and we, as physician-scientists, are taking this threat seriously. In light of the available data, we act diligently to protect those most vulnerable in this situation: our cancer patients. The necessary measures to mitigate the spread of